Sweden: state board, and what it actually costs here
Sweden: state board, and what it actually costs here, and I am aware this is a minority view on this board. Concentration on the compounded vial was different from what I had been using and I nearly did the arithmetic on autopilot. Asked for the beyond-use date basis and got a real answer with a stability reference…
The shortage list is the legal hinge: the permissions that allow certain compounding to happen at scale are tied to a drug’s shortage status, which changes.
Yes — asking which facility, by name, is the single most useful question and most clinics will answer it.
the shortage list is the whole legal hinge and people skip it
the shortage list is the whole legal hinge and people skip it
This is the distinction the whole board runs on. Everything else follows from it.
Yes. The shortage list is the legal hinge for the whole arrangement and its status is public.
the API source is the question nobody asks and everybody should
Correction: patient-specific refers to the prescription, not to a bespoke formulation. Common misreading and it changes the argument.
a 503B has to register and report, so there is a paper trail to ask for